# A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood

> **NCT07753174** · NA · RECRUITING · sponsor: **Revive Active** · enrollment: 49 (estimated)

## Conditions studied

- Omega-3 Deficiency
- DHA and EPA Blood Levels
- Cardiovascular Health
- Cognitive Health

## Interventions

- **DIETARY_SUPPLEMENT:** Omega Active Supplement

## Key facts

- **NCT ID:** NCT07753174
- **Lead sponsor:** Revive Active
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753174, "A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07753174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*